Ordered Labeling-Facilitated Electrochemical Assay of Alpha-Fetoprotein-L3 Ratio for Diagnosing Hepatocellular Carcinoma
ACS Applied Materials & Interfaces · 2023
DOI: 10.1021/acsami.2c19231 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, 2023. Written by Yingyan Zhao and 6 co-authors. Institution: Center for Molecular Recognition and Biosensing, Shanghai Engineering Research Center of Organ Repair, School of Life Sciences, Shanghai University, …. Major MEDLINE topics: Carcinoma, Hepatocellular, Liver Neoplasms, Metal Nanoparticles. Cited 18 times so far (Crossref); 33 references. Funded by: National Natural Science Foundation of China.
Abstract (original language)
Serum alpha fetoprotein (AFP) is a "gold-standard" biomarker for the diagnosis of hepatocellular carcinoma (HCC). Available pieces of evidence suggest that the ratio of AFP-L3 isoform in the total AFP may provide more accurate prediction for the incidence of HCC. In this work, we design an electrochemical aptasensor for high-accuracy assay of AFP-L3 ratio based on differentiated labeling of AFP isoforms in an orderly fashion. Specifically, total AFP is first captured by an AFP aptamer-functionalized electrode and labeled with quantum dots-functionalized DNA probes via mild reduction. Then, AFP-L3 isoform that strongly binds to Lens culinaris agglutinin is labeled with silver nanoparticles after the exonuclease-catalyzed removal of DNA probes. By tracing the electrochemical responses of quantum dots and silver nanoparticles, respectively, the amounts of total AFP and AFP-L3 isoforms are determined and the AFP-L3 ratio is accordingly calculated to favor the accurate HCC diagnosis. Experimental results prove the high-accuracy assay of AFP-L3 ratio based on the AFP quantitation in a linear range of 0.0008-40 ng mL-1 and AFP-L3 quantitation in a linear range of 0.004-40 ng mL-1. The aptasensor also displays satisfactory specificity and good recoveries even in the complex serum samples. Therefore, the aptasensor may provide a valuable tool for the assay of the AFP-L3 ratio and have a great potential use in early warning of HCC for clinical application.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Center for Molecular Recognition and Biosensing, Shanghai Engineering Research Center of Organ Repair, School of Life Sciences, Shanghai University, Shanghai 200444, China.
- Department of Geriatric Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China.
- Department of Gastroenterology, Dongying People's Hospital, Dongying 257091, China.
Funding
- National Natural Science Foundation of China
Cite
APA
Zhao, Y., Liu, Q., Qin, Y., Cao, Y., Zhao, J., Zhang, K., & Cao, Y. (2023). Ordered Labeling-Facilitated Electrochemical Assay of Alpha-Fetoprotein-L3 Ratio for Diagnosing Hepatocellular Carcinoma. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.2c19231
Vancouver
Zhao Y, Liu Q, Qin Y, Cao Y, Zhao J, Zhang K, et al. Ordered Labeling-Facilitated Electrochemical Assay of Alpha-Fetoprotein-L3 Ratio for Diagnosing Hepatocellular Carcinoma. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.2c19231
BibTeX
@article{Zhao2023,
author = {Zhao, Yingyan and Liu, Qi and Qin, Yujia and Cao, Yue and Zhao, Jing and Zhang, Kai and Cao, Ya},
title = {Ordered Labeling-Facilitated Electrochemical Assay of Alpha-Fetoprotein-L3 Ratio for Diagnosing Hepatocellular Carcinoma},
journal = {ACS Applied Materials & Interfaces},
year = {2023},
doi = {10.1021/acsami.2c19231}
}
EUVIMED